Endocrine Effects Research has explored DSIPs ability to modulate the release of various hormones such as luteinizing hormone (LH), growth hormone (GH), and corticotropin
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
A rejection, delay, label limitation, or additional trial requirement would also matter
Some find administering DSIP 3 hours before bed, allowing the initial effects to settle before sleep attempt, produces the best results
The clinician will review your symptoms, medical history, and previous treatments to determine whether the injection is suitable for you
Lancet Child and Adolesc